Maze Therapeutics (MAZE) Stock Chart & Stock Price History $30.39 +0.49 (+1.64%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Maze Therapeutics Stock Price Performance The Maze Therapeutics (MAZE) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 16.08%, reflecting recent market activity. As of the latest close, Maze Therapeutics traded at $29.90 with a market cap of $1.31 billion and volume of 267,875 shares. Receive MAZE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+9.28%1 Month Performance+16.08%3 Month Performance+84.74% MAZE Stock Chart for Friday, October, 24, 2025 MAZE Chart by TradingView Maze Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/24/2025$29.90$30.39+1.64%$30.95$29.28286,991 shs$1.33 billion10/23/2025$29.12$29.90+2.68%$31.10$29.10267,875 shs$1.31 billion10/22/2025$29.52$29.12-1.36%$30.26$28.98367,185 shs$1.28 billion10/21/2025$29.75$29.52-0.77%$31.93$29.00280,001 shs$1.29 billion10/20/2025$27.81$29.75+6.98%$29.86$27.79387,318 shs$1.30 billion10/17/2025$28.45$27.81-2.25%$29.10$27.54194,988 shs$1.22 billion10/16/2025$29.26$28.45-2.77%$29.76$28.17235,103 shs$1.28 billion10/15/2025$28.50$29.26+2.67%$29.44$28.31425,480 shs$1.28 billion10/14/2025$28.57$28.50-0.25%$29.09$28.20210,824 shs$1.25 billion10/13/2025$27.43$28.57+4.16%$29.15$27.41590,488 shs$1.25 billion Get the Latest News and Ratings for MAZE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/10/2025$28.76$27.43-4.62%$29.45$27.34261,742 shs$1.20 billion10/09/2025$28.59$28.76+0.59%$29.16$28.20296,940 shs$1.26 billion10/08/2025$27.86$28.59+2.62%$29.66$26.63770,815 shs$1.25 billion10/07/2025$27.52$27.86+1.24%$28.12$26.97348,288 shs$1.22 billion10/06/2025$27.11$27.52+1.51%$28.78$26.43311,067 shs$1.21 billion10/03/2025$26.50$27.11+2.30%$27.80$25.88405,456 shs$1.19 billion10/02/2025$25.81$26.50+2.67%$26.79$24.99305,509 shs$1.16 billion10/01/2025$25.93$25.81-0.46%$26.39$25.45307,669 shs$1.13 billion09/30/2025$25.20$25.93+2.90%$26.45$24.42479,937 shs$1.14 billion09/29/2025$27.00$25.20-6.67%$27.83$24.85476,334 shs$1.11 billion09/26/2025$26.35$27.00+2.47%$28.37$26.04609,163 shs$1.18 billion09/25/2025$26.18$26.35+0.65%$27.67$25.90747,137 shs$1.16 billion09/24/2025$24.88$26.18+5.23%$27.65$24.97975,877 shs$1.15 billion09/23/2025$23.67$24.88+5.11%$25.17$23.34430,614 shs$1.09 billion Related Companies Arcellx Stock Chart Protagonist Therapeutics Stock Chart Jyong Biotech Stock Chart Kymera Therapeutics Stock Chart Akero Therapeutics Stock Chart NewAmsterdam Pharma Stock Chart Crinetics Pharmaceuticals Stock Chart Viking Therapeutics Stock Chart Gemini Therapeutics Stock Chart Lantheus Stock Chart Receive MAZE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MAZE) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredTrade this between 9:30 and 10:45 am ESTIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maze Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maze Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MAZE Stock Alerts